|
Market Closed -
NSE India S.E.
07:05:08 2026-10-13 EDT
|
5-day change | 1st Jan Change | ||
| 222.52 INR | -1.36% |
|
-4.76% | +15.53% |
| Market Cap | 14.67B 155M 138M 129M 117M 220M 221M 1.54B 603M 7.63B 580M 568M 24.48B | P/E 2025 |
26.4x | P/E 2026 | 29.1x |
|---|---|---|---|---|---|
| Enterprise Value | 13.69B 144M 129M 120M 109M 205M 207M 1.44B 563M 7.12B 542M 530M 22.85B | EV / Sales 2025 |
4.92x | EV / Sales 2026 | 3.95x |
| Free-Float |
24.06% | Yield 2025 |
1.15% | Yield 2026 | 1.36% |
NSE India S.E.INR
| Markets | Quality | ||
|---|---|---|---|
NSE India S.E.
| JAGSNPHARM | Delayed | |
Bombay S.E.
| 507789 | Delayed |
| 22-08-29 | Jagsonpal Pharmaceuticals : ESOP/ESPS/SBEB Scheme | PU |
| 22-08-16 | Jagsonpal Pharmaceuticals : Reply to Clarification Sought | PU |
| 22-07-16 | Jagsonpal Pharmaceuticals : Appointment | PU |
| 1 day | -1.36% | ||
| 1 week | -4.76% | ||
| Current month | -6.40% | ||
| 1 month | -4.45% | ||
| 3 months | -3.28% | ||
| 6 months | +14.34% | ||
| Current year | +15.53% |
| 1 week | 219.8 |  | 237.79 |
| 1 month | 217.81 | | 251 |
| Current year | 155 | | 264.5 |
| 1 year | 155 | | 264.5 |
| 3 years | 109.44 | | 328.04 |
| 5 years | 49.2 | | 328.04 |
| 10 years | 6.5 | | 328.04 |
| Manager | Title | Age | Since |
|---|---|---|---|
Manish Gupta
CEO | Chief Executive Officer | 59 | 2022-07-15 |
| Director of Finance/CFO | - | 2025-10-06 | |
Amrut Medhekar
COO | Chief Operating Officer | - | 2025-09-03 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 69 | 2013-12-03 | |
Harsha Raghavan
CHM | Chairman | 55 | 2022-07-15 |
| Director/Board Member | - | 2022-06-28 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.36% | -4.76% | +2.77% | +31.20% | 156M | |
| -1.36% | +0.78% | +42.36% | +91.48% | 1,054B | |
| -5.73% | -2.42% | +30.23% | +58.50% | 636B | |
| -2.40% | +2.88% | +19.13% | +85.43% | 497B | |
| -2.39% | +0.03% | +65.67% | +36.51% | 359B | |
| -0.06% | +2.86% | +24.03% | +41.07% | 345B | |
| -0.55% | +1.81% | +14.16% | +36.31% | 273B | |
| -1.08% | -0.52% | -6.51% | +8.40% | 246B | |
| -1.13% | +2.54% | +41.19% | +45.32% | 226B | |
| -1.67% | +2.56% | +25.13% | +90.50% | 187B | |
| Average | -1.49% | +2.12% | +25.82% | +52.47% | 382.24B | |
| Weighted average by Cap. | -1.36% | +2.44% | +31.78% | +63.42% |
| 2025 | 2026 | |
|---|---|---|
| Net sales | 2.69B 28.31M 25.29M 23.57M 21.37M 40.22M 40.53M 282M 111M 1.4B 106M 104M 4.48B | 2.87B 30.26M 27.03M 25.19M 22.84M 42.99M 43.32M 302M 118M 1.49B 114M 111M 4.79B |
| Net income | 554M 5.83M 5.21M 4.86M 4.4M 8.29M 8.35M 58.17M 22.77M 288M 21.9M 21.42M 924M | 431M 4.54M 4.05M 3.78M 3.43M 6.45M 6.5M 45.27M 17.72M 224M 17.05M 16.67M 719M |
| Net Debt | -1.19B -12.59M -11.25M -10.48M -9.5M -17.88M -18.02M -126M -49.15M -621M -47.28M -46.24M -1.99B | -976M -10.29M -9.19M -8.56M -7.76M -14.61M -14.73M -103M -40.17M -508M -38.63M -37.78M -1.63B |
Employees
1,297
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-10-13 | ₹222.52 | -1.36% | 96,666 |
| 26-10-12 | ₹225.58 | -0.01% | 44,417 |
| 26-10-09 | ₹225.60 | -2.63% | 50,851 |
| 26-10-08 | ₹231.70 | -1.57% | 49,600 |
| 26-10-07 | ₹235.40 | +0.76% | 164,193 |
- Stock Market
- Stocks
- JAGSNPHARM Stock
Select your edition
All financial news and data tailored to specific country editions
